Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review

Graphical abstract

[1]  D. Schmaljohann.  Thermo- and pH-responsive polymers in drug delivery. , 2006, Advanced drug delivery reviews.

[2]  María Vallet-Regí,et al.  Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers. , 2015, ACS nano.

[3]  Suthida Boonsith,et al.  The Practicality of Mesoporous Silica Nanoparticles as Drug Delivery Devices and Progress Toward This Goal , 2014, AAPS PharmSciTech.

[4]  Christopher R Williams,et al.  New Dendrimers: Synthesis and Characterization of Popam - Pamam Hybrid Dendrimers. , 2008, Macromolecules.

[5]  A. L. D. de Barros,et al.  Functionalized single-walled carbon nanotubes: cellular uptake, biodistribution and applications in drug delivery. , 2017, International journal of pharmaceutics.

[6]  Amit K Jain,et al.  Toxicity of multiwalled carbon nanotubes with end defects critically depends on their functionalization density. , 2011, Chemical research in toxicology.

[7]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[8]  Xing Ma,et al.  Functional mesoporous silica nanoparticles for photothermal-controlled drug delivery in vivo. , 2012, Angewandte Chemie.

[9]  Jing Zhu,et al.  The Advances of Carbon Nanotubes in Cancer Diagnostics and Therapeutics , 2017 .

[10]  A. Caminade.  Phosphorus dendrimers for nanomedicine. , 2017, Chemical communications.

[11]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[12]  Antonios G Mikos,et al.  Thermoresponsive hydrogels in biomedical applications. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  Hongjie Hu,et al.  Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Yoshihiro Takeda,et al.  Full Physical Preparation of Size-Selected Gold Nanoparticles in Solution: Laser Ablation and Laser-Induced Size Control , 2002 .

[15]  Jun Chen,et al.  External-stimuli responsive systems for cancer theranostic , 2016 .

[16]  Amarnath Sharma,et al.  Liposomes in drug delivery: Progress and limitations , 1997 .

[17]  R. P. Andres,et al.  Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells. , 2006, Bioconjugate chemistry.

[18]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[19]  K. Al‐Jamal,et al.  The interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivo , 2015, Biomaterials.

[20]  Mark E. Davis,et al.  Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core , 2015, Proceedings of the National Academy of Sciences.

[21]  David H. Thompson,et al.  Stimuli-responsive liposomes for drug delivery. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[22]  M. R. Mozafari,et al.  Cytotoxicity evaluation of anionic nanoliposomes and nanolipoplexes prepared by the heating method without employing volatile solvents and detergents. , 2007, Die Pharmazie.

[23]  T. Andresen,et al.  In vitro toxicity of cationic micelles and liposomes in cultured human hepatocyte (HepG2) and lung epithelial (A549) cell lines. , 2016, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  Jing Liu,et al.  Functionalized carbon nanotubes for anticancer drug delivery , 2011, Expert review of medical devices.

[25]  S. Libutti,et al.  Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect , 2007, Clinical Cancer Research.

[26]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[27]  P K Gupta,et al.  Drug targeting in cancer chemotherapy: a clinical perspective. , 1990, Journal of pharmaceutical sciences.

[28]  Vincent M Rotello,et al.  Functionalized gold nanoparticles for drug delivery. , 2007, Nanomedicine.

[29]  Laetitia Gonzalez,et al.  Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. , 2009, Small.

[30]  Tingting Zhao,et al.  Ratiometric and time-resolved fluorimetry from quantum dots featuring drug carriers for real-time monitoring of drug release in situ. , 2014, Analytical chemistry.

[31]  K. Letchford,et al.  A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  D. Leeper,et al.  Extracellular pH distribution in human tumours. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[33]  Shanshan Qi,et al.  Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy , 2017, Drug delivery.

[34]  Linlin Li,et al.  Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.

[35]  A. Mohammed,et al.  Trigger release liposome systems: local and remote controlled delivery? , 2012, Journal of microencapsulation.

[36]  K. Okuyama,et al.  Synthesis of spherical mesoporous silica nanoparticles with nanometer-size controllable pores and outer diameters , 2009 .

[37]  Jianhua Zhang,et al.  PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin. , 2014, Biomacromolecules.

[38]  C. Hawker,et al.  Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .

[39]  T. Allen,et al.  Ligand-targeted liposomal anticancer drugs. , 2003, Progress in lipid research.

[40]  W. Wang,et al.  Unique Roles of Gold Nanoparticles in Drug Delivery, Targeting and Imaging Applications , 2017, Molecules.

[41]  Jonathan D. Ashley,et al.  Ligand-targeted liposome design: challenges and fundamental considerations. , 2014, Trends in biotechnology.

[42]  Edward Chu,et al.  A history of cancer chemotherapy. , 2008, Cancer research.

[43]  S. Murdan.  Electro-responsive drug delivery from hydrogels. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[44]  A. S. Moses,et al.  Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.

[45]  Morteza Milani,et al.  Dendrimers: synthesis, applications, and properties , 2014, Nanoscale Research Letters.

[46]  Kinam Park,et al.  Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities. , 2015, Chemical engineering science.

[47]  Mark Green,et al.  Some aspects of quantum dot toxicity. , 2011, Chemical communications.

[48]  T. Okano,et al.  Targetable drug carriers: present status and a future perspective , 1996 .

[49]  Z. Dai,et al.  Microwave-Triggered Smart Drug Release from Liposomes Co-encapsulating Doxorubicin and Salt for Local Combined Hyperthermia and Chemotherapy of Cancer. , 2016, Bioconjugate chemistry.

[50]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Zhong-gao Gao,et al.  Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. , 2007, Journal of the National Cancer Institute.

[52]  Y. Liu,et al.  Reverse micelle-based water-soluble nanoparticles for simultaneous bioimaging and drug delivery. , 2017, Organic & biomolecular chemistry.

[53]  Yingge Zhang,et al.  The application of carbon nanotubes in target drug delivery systems for cancer therapies , 2011, Nanoscale research letters.

[54]  G. Oberdörster,et al.  Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology , 2010, Journal of internal medicine.

[55]  Hsiu-Mei Lin,et al.  Preparation and characterization of multifunctional mesoporous silica nanoparticles for dual magnetic resonance and fluorescence imaging in targeted cancer therapy , 2017 .

[56]  Dean-Mo Liu,et al.  Core/Single‐Crystal‐Shell Nanospheres for Controlled Drug Release via a Magnetically Triggered Rupturing Mechanism , 2008, Advanced materials.

[57]  M. Abidian,et al.  Conducting‐Polymer Nanotubes for Controlled Drug Release , 2006, Advanced materials.

[58]  Ande Bao,et al.  Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. , 2012, Bioconjugate chemistry.

[59]  H. Nishigori,et al.  Optimal radiolabeled liposomes for tumor imaging. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  K. Kuroda,et al.  Preparation of size-controlled monodisperse colloidal mesoporous silica nanoparticles and fabrication of colloidal crystals , 2014 .

[61]  George R. Newkome,et al.  MICELLES. PART 1. CASCADE MOLECULES: A NEW APPROACH TO MICELLES. A (27)-ARBOROL , 1985 .

[62]  O Zumbuehl,et al.  Liposomes of controllable size in the range of 40 to 180 nm by defined dialysis of lipid/detergent mixed micelles. , 1981, Biochimica et biophysica acta.

[63]  Sumit Arora,et al.  Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers , 2012, International journal of nanomedicine.

[64]  G. Weissmann,et al.  The action of steroids and streptolysin S on the permeability of phospholipid structures to cations. , 1965, Journal of molecular biology.

[65]  P. Kesharwani,et al.  Dendrimer toxicity: Let's meet the challenge. , 2010, International journal of pharmaceutics.

[66]  M. Parnham,et al.  Toxicity screening of liposomes. , 1993, Chemistry and physics of lipids.

[67]  Wei Huang,et al.  Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment , 2015, Acta pharmaceutica Sinica. B.

[68]  Elena Aznar,et al.  Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field. , 2012, Chemical communications.

[69]  Luwei Zhang,et al.  Gold Nanoparticle Mediated Phototherapy for Cancer , 2016 .

[70]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[71]  Xiaohu Gao,et al.  Emerging application of quantum dots for drug delivery and therapy. , 2008, Expert opinion on drug delivery.

[72]  C. Gaillard,et al.  Carbon nanotube‐coupled cell adhesion peptides are non‐immunogenic: a promising step toward new biomedical devices , 2011, Journal of peptide science : an official publication of the European Peptide Society.

[73]  Norased Nasongkla,et al.  Functionalized Micellar Systems for Cancer Targeted Drug Delivery , 2007, Pharmaceutical Research.

[74]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[75]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[76]  Eleanor Stride,et al.  Liposome production by microfluidics: potential and limiting factors , 2016, Scientific Reports.

[77]  Yazhou Wang,et al.  The application of thermosensitive nanocarriers in controlled drug delivery , 2011 .

[78]  Chandana Mohanty,et al.  Receptor mediated tumor targeting: an emerging approach for cancer therapy. , 2011, Current drug delivery.

[79]  J. Kreuter.  Nanoparticles--a historical perspective. , 2007, International journal of pharmaceutics.

[80]  Jianlin Shi,et al.  Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility , 2011 .

[81]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[82]  H. Kim,et al.  Tumor-Targeting Co-Delivery of Drug and Gene from Temperature-Triggered Micelles. , 2015, Macromolecular bioscience.

[83]  Younes Ghasemi,et al.  Quantum dot: magic nanoparticle for imaging, detection and targeting. , 2009, Acta bio-medica : Atenei Parmensis.

[84]  A. Seifalian,et al.  A new era of cancer treatment: carbon nanotubes as drug delivery tools , 2011, International journal of nanomedicine.

[85]  J. Shea,et al.  Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[86]  K. Al‐Jamal,et al.  Functionalized carbon nanotubes: revolution in brain delivery. , 2015, Nanomedicine.

[87]  H. Hatcher,et al.  Anticancer chemotherapy in teenagers and young adults: managing long term side effects , 2016, British Medical Journal.

[88]  C. L. Ventola,et al.  Progress in Nanomedicine: Approved and Investigational Nanodrugs. , 2017, P & T : a peer-reviewed journal for formulary management.

[89]  G. Kwon,et al.  Polymeric micelle nanocarriers in cancer research , 2016, Frontiers of Chemical Science and Engineering.

[90]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[91]  Mohammad Abdollahi,et al.  Toxicity of Nanoparticles and an Overview of Current Experimental Models , 2016, Iranian biomedical journal.

[92]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[93]  D. Peer,et al.  Grand challenges in modulating the immune response with RNAi nanomedicines. , 2011, Nanomedicine.

[94]  Jennifer I. Hare,et al.  Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.

[95]  Ian D. McGilvray,et al.  Mechanism of hard nanomaterial clearance by the liver , 2016, Nature materials.

[96]  Rakesh K. Jain,et al.  Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.

[97]  Erik C. Dreaden,et al.  Size matters: gold nanoparticles in targeted cancer drug delivery. , 2012, Therapeutic delivery.

[98]  T. Okano,et al.  Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[99]  Dong Liang,et al.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.

[100]  Evaluation of quantum dot cytotoxicity: interpretation of nanoparticle concentrations versus intracellular nanoparticle numbers , 2016, Nanotoxicology.

[101]  B. Nanjwade,et al.  Dendrimers: emerging polymers for drug-delivery systems. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[102]  M. Yokoyama,et al.  Histological study on side effects and tumor targeting of a block copolymer micelle on rats. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[103]  Liangzhu Feng,et al.  Near-infrared-light responsive nanoscale drug delivery systems for cancer treatment , 2016 .

[104]  Vincent M Rotello,et al.  Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.

[105]  N. Jeon,et al.  Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU , 2019, Journal of liposome research.

[106]  T. Yen,et al.  The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas. , 2011, Biomaterials.

[107]  S. Tofail,et al.  Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles , 2018, Biochemistry and biophysics reports.

[108]  Hang Xie,et al.  Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment , 2016, Scientific Reports.

[109]  Mei-xia Zhao,et al.  The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy , 2016, Nanoscale Research Letters.

[110]  Paresh Chandra Ray,et al.  Challenge in Understanding Size and Shape Dependent Toxicity of Gold Nanomaterials in Human Skin Keratinocytes. , 2008, Chemical physics letters.

[111]  Young-Seak Lee,et al.  The effect of carbon nanotubes on drug delivery in an electro-sensitive transdermal drug delivery system. , 2010, Biomaterials.

[112]  Wei Qian,et al.  Highly Efficient and Controllable PEGylation of Gold Nanoparticles Prepared by Femtosecond Laser Ablation in Water , 2011 .

[113]  P. MacEneaney,et al.  Pharmacokinetics and bio‐distribution of novel super paramagnetic iron oxide nanoparticles (SPIONs) in the anaesthetized pig , 2016, Clinical and experimental pharmacology & physiology.

[114]  Qinfu Zhao,et al.  A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics , 2017, Scientific Reports.

[115]  M. Ibrahim,et al.  Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp , 2015, Cancer Cell International.

[116]  Steffen Loft,et al.  In vivo toxicity of cationic micelles and liposomes. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[117]  B. Chabner,et al.  Chemotherapy and the war on cancer , 2005, Nature Reviews Cancer.

[118]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[119]  Ventola Cl,et al.  Progress in Nanomedicine: Approved and Investigational Nanodrugs. , 2017 .

[120]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[121]  Kristofer J. Thurecht,et al.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date , 2016, Pharmaceutical Research.

[122]  W. Hennink,et al.  Reduction-sensitive polymers and bioconjugates for biomedical applications. , 2009, Biomaterials.

[123]  Ron C. Hardman.  A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.

[124]  Ken-Tye Yong,et al.  Immunotoxicity assessment of CdSe/ZnS quantum dots in macrophages, lymphocytes and BALB/c mice , 2016, Journal of Nanobiotechnology.

[125]  Jinming Gao,et al.  Multifunctional Micellar Nanomedicine for Cancer Therapy , 2009, Experimental biology and medicine.

[126]  Ghulam Murtaza,et al.  Gold Nanoparticles: Synthesis and Applications in Drug Delivery , 2014 .

[127]  D. Brühwiler.  Postsynthetic functionalization of mesoporous silica. , 2010, Nanoscale.

[128]  N. P. Ulrih,et al.  Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics. , 2013, Cancer letters.

[129]  C. Cametti,et al.  How toxic are gold nanoparticles? The state-of-the-art , 2015, Nano Research.

[130]  R. Bosetti.  Cost-effectiveness of nanomedicine: the path to a future successful and dominant market? , 2015, Nanomedicine.

[131]  S. D. De Smedt,et al.  Crucial factors and emerging concepts in ultrasound-triggered drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[132]  Y. Rojanasakul,et al.  Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes , 2000, Pharmaceutical Research.

[133]  Thomas L Andresen,et al.  Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review) , 2010, Molecular membrane biology.

[134]  A. R. Fernandes,et al.  Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer—The Case for Combined Delivery? , 2017, Genes.

[135]  T. Andresen,et al.  Differential toxicological response to positively and negatively charged nanoparticles in the rat brain , 2013, Nanotoxicology.

[136]  Abdallah S. Daar,et al.  State of Academic Knowledge on Toxicity and Biological Fate of Quantum Dots , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[137]  O. Boutin,et al.  Preparation of liposomes using the supercritical anti-solvent (SAS) process and comparison with a conventional method , 2011 .

[138]  James R. Dewald,et al.  A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .

[139]  R Langer,et al.  Responsive polymeric delivery systems. , 2001, Advanced drug delivery reviews.

[140]  V. Jansons,et al.  Control of in vitro cytotoxicity of positively charged liposomes , 1979, Journal of Cancer Research and Clinical Oncology.

[141]  Y. Hung,et al.  Assessment of the In Vivo Toxicity of Gold Nanoparticles , 2009, Nanoscale research letters.

[142]  T. Bein,et al.  Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery. , 2015, Nanoscale.

[143]  R. Kumar,et al.  In Vitro Evaluation of Theranostic Polymeric Micelles for Imaging and Drug Delivery in Cancer , 2012, Theranostics.

[144]  S. Iijima.  Helical microtubules of graphitic carbon , 1991, Nature.

[145]  Jinatta Jittiwat,et al.  Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. , 2010, Biomaterials.

[146]  P. Speiser,et al.  Bead polymerization technique for sustained-release dosage form. , 1970, Journal of pharmaceutical sciences.

[147]  A. Salgado,et al.  In vivo biodistribution of carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles in rats , 2011 .

[148]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[149]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[150]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[151]  Zhiyang Li,et al.  Nanocarriers in gene therapy: a review. , 2014, Journal of biomedical nanotechnology.

[152]  Gonçalo Doria,et al.  Noble Metal Nanoparticles Applications in Cancer , 2011, Journal of drug delivery.

[153]  R. Shukla,et al.  Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[154]  Erkki Ruoslahti,et al.  Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles , 2012, Advanced materials.

[155]  K. Kataoka,et al.  Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.

[156]  Mauro Ferrari,et al.  Seven challenges for nanomedicine. , 2008, Nature nanotechnology.

[157]  P. Maiti,et al.  Controlled drug delivery vehicles for cancer treatment and their performance , 2018, Signal Transduction and Targeted Therapy.

[158]  D. Appelhans,et al.  In vivo toxicity of poly(propyleneimine) dendrimers. , 2011, Journal of biomedical materials research. Part A.

[159]  Jianwen Liu,et al.  In vitro toxicity of silica nanoparticles in myocardial cells. , 2010, Environmental toxicology and pharmacology.

[160]  Krishna R. Raghupathi,et al.  Stimuli Sensitive Amphiphilic Dendrimers. , 2012, New journal of chemistry = Nouveau journal de chimie.

[161]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[162]  M. Bertino,et al.  Quantum dots by ultraviolet and x-ray lithography , 2007 .

[163]  D. Tomalia,et al.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.

[164]  S. Galvagno,et al.  Graphene quantum dots for cancer targeted drug delivery. , 2017, International journal of pharmaceutics.

[165]  Qasim Chaudhry,et al.  A complementary definition of nanomaterial , 2010 .

[166]  Umesh Gupta,et al.  Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. , 2007, Biomaterials.

[167]  John Robertson,et al.  Catalytic chemical vapor deposition of single-wall carbon nanotubes at low temperatures. , 2006, Nano letters.

[168]  Luigi Naldini,et al.  Gene therapy returns to centre stage , 2015, Nature.

[169]  Z. Qian,et al.  The in vitro and in vivo toxicity of gold nanoparticles , 2017 .

[170]  A. Dinda,et al.  Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress , 2010, International journal of nanomedicine.

[171]  Viney Lather,et al.  Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues , 2014, Journal of pharmacy & bioallied sciences.

[172]  Yang Li,et al.  Shell-detachable micelles based on disulfide-linked block copolymer as potential carrier for intracellular drug delivery. , 2009, Bioconjugate chemistry.

[173]  Seungpyo Hong,et al.  Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting , 2015, Journal of drug targeting.

[174]  D. Yee,et al.  Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. , 2008, Nanomedicine.

[175]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges , 2014, Expert opinion on drug delivery.

[176]  Paul M. George,et al.  Electrically Controlled Drug Delivery from Biotin‐Doped Conductive Polypyrrole , 2006 .

[177]  Dipak Maity,et al.  Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics. , 2015, International journal of pharmaceutics.

[178]  Mengrui Liu,et al.  Internal stimuli-responsive nanocarriers for drug delivery: Design strategies and applications. , 2017, Materials science & engineering. C, Materials for biological applications.

[179]  Zhiyuan Zhong,et al.  Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[180]  Yiyun Cheng,et al.  Stimuli-responsive dendrimers in drug delivery. , 2016, Biomaterials science.

[181]  A. Jeffreys,et al.  Individual-specific ‘fingerprints’ of human DNA , 1985, Nature.

[182]  Xiaohu Gao,et al.  Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand release. , 2012, ACS nano.

[183]  H. Ghandehari,et al.  Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery. , 2012, Advanced drug delivery reviews.

[184]  A. Bangham,et al.  PROPERTIES AND USES OF LIPID VESICLES: AN OVERVIEW , 1978, Annals of the New York Academy of Sciences.

[185]  Donald A. Tomalia,et al.  Visualization of Dendrimer Molecules by Transmission Electron Microscopy (TEM): Staining Methods and Cryo-TEM of Vitrified Solutions , 1998 .

[186]  A. Molinari,et al.  Liposomes as nanomedical devices , 2015, International journal of nanomedicine.

[187]  Jeffrey I Zink,et al.  Light-activated nanoimpeller-controlled drug release in cancer cells. , 2008, Small.

[188]  C. Haynes,et al.  Synthesis and Characterization of Biocompatible and Size-Tunable Multifunctional Porous Silica Nanoparticles , 2009 .

[189]  Xin Xin,et al.  Nanomedicine‐based combination anticancer therapy between nucleic acids and small‐molecular drugs☆ , 2017, Advanced drug delivery reviews.

[190]  Jianlin Shi,et al.  The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. , 2010, Biomaterials.

[191]  Victor C Yang,et al.  Cancer theranostics: the rise of targeted magnetic nanoparticles. , 2011, Trends in biotechnology.

[192]  G Gregoriadis,et al.  Drug entrapment in liposomes , 1973, FEBS letters.

[193]  G. Golomb,et al.  Route of administration-dependent anti-inflammatory effect of liposomal alendronate. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[194]  P. Fisher,et al.  Gene Therapies for Cancer: Strategies, Challenges and Successes , 2015, Journal of cellular physiology.

[195]  Jiajun Fu,et al.  Recent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor Treatment , 2016, Molecules.

[196]  U. Schubert,et al.  Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.

[197]  W. Krätschmer,et al.  Solid C60: a new form of carbon , 1990, Nature.

[198]  Seyed Moein Moghimi,et al.  Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions , 2009, Journal of liposome research.

[199]  G. Nowak,et al.  The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies , 2015, Pharmacological reports : PR.

[200]  Soodabeh Davaran,et al.  Quantum dots: synthesis, bioapplications, and toxicity , 2012, Nanoscale Research Letters.

[201]  Huan Yang,et al.  Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance , 2012, International journal of nanomedicine.

[202]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[203]  Soodabeh Davaran,et al.  Liposome: classification, preparation, and applications , 2013, Nanoscale Research Letters.

[204]  Yuanhui Song,et al.  Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook , 2016, International journal of nanomedicine.

[205]  J. Kost,et al.  Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. , 2009, Chemistry and physics of lipids.

[206]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[207]  M. Kamal,et al.  Nanotechnology-based approaches in anticancer research , 2012, International journal of nanomedicine.

[208]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[209]  F. Szoka,et al.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[210]  O. Planinšek,et al.  Stimulus-responsive mesoporous silica particles , 2013, Journal of Materials Science.

[211]  D. Chiappetta,et al.  Polymeric mixed micelles as nanomedicines: Achievements and perspectives. , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[212]  Yubin Cao,et al.  Toxicity assessment of nanoparticles in various systems and organs , 2017 .

[213]  Catherine J. Murphy,et al.  Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.

[214]  J. Shea,et al.  Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[215]  Marco Guida,et al.  Toxicity Effects of Functionalized Quantum Dots, Gold and Polystyrene Nanoparticles on Target Aquatic Biological Models: A Review , 2017, Molecules.

[216]  J. Lee,et al.  Carbon nanotubes as cancer therapeutic carriers and mediators , 2016, International journal of nanomedicine.

[217]  E. W. Meijer,et al.  About Dendrimers: Structure, Physical Properties, and Applications. , 1999, Chemical reviews.

[218]  Hideki Sakai,et al.  Preparation of liposomes using an improved supercritical reverse phase evaporation method. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[219]  V. Préat,et al.  In vitro investigations of smart drug delivery systems based on redox-sensitive cross-linked micelles. , 2013, Macromolecular bioscience.

[220]  M. Melancon,et al.  Stimuli-Responsive Gold Nanoparticles for Cancer Diagnosis and Therapy , 2016, Journal of functional biomaterials.

[221]  Angelo Bifone,et al.  In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry. , 2013, Molecular pharmaceutics.

[222]  T. Asefa,et al.  Biocompatibility of mesoporous silica nanoparticles. , 2012, Chemical research in toxicology.

[223]  Abhay Asthana,et al.  Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient , 2005, AAPS PharmSciTech.

[224]  C. Breathnach.  Magnetism in medicine. , 1983, Irish medical journal.

[225]  Prashant K. Sharma,et al.  Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment. , 2015, ACS applied materials & interfaces.

[226]  H. Kato,et al.  Size effects of single-walled carbon nanotubes on in vivo and in vitro pulmonary toxicity , 2015, Inhalation toxicology.

[227]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[228]  Patrice Marche,et al.  Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.

[229]  S. Mousa,et al.  Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy , 2015, Nanomaterials.

[230]  M. Hatami.  Toxicity assessment of multi-walled carbon nanotubes on Cucurbita pepo L. under well-watered and water-stressed conditions. , 2017, Ecotoxicology and environmental safety.

[231]  T. Mocan,et al.  Quantum dots in imaging, drug delivery and sensor applications , 2017, International journal of nanomedicine.

[232]  George R. Newkome,et al.  Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol , 1985 .

[233]  Kristen N. Duthie,et al.  Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. , 2008, Nano letters.

[234]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[235]  H. Byrne,et al.  Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers , 2018, International journal of environmental research and public health.

[236]  Yuko Nakamura,et al.  Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? , 2016, Bioconjugate chemistry.

[237]  Yanzhi Song,et al.  Progress involving new techniques for liposome preparation , 2014 .

[238]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[239]  Miqin Zhang,et al.  Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics , 2013, Expert opinion on drug delivery.

[240]  I. Jang,et al.  Effect of micro/nano silica particle feeding for mice. , 2008, Journal of nanoscience and nanotechnology.

[241]  Matthew Tirrell,et al.  In vivo biodistribution and clearance of peptide amphiphile micelles. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[242]  Alexander P. Savitsky,et al.  Biodistribution and clearance of quantum dots in small animals , 2010, Saratov Fall Meeting.

[243]  D. Korolev,et al.  In Vivo Toxicity of Intravenously Administered Silica and Silicon Nanoparticles , 2012, Materials.

[244]  C. Nilsson,et al.  Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry. , 2003, Methods in cell science : an official journal of the Society for In Vitro Biology.

[245]  Gareth J.S. Jenkins,et al.  Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION) , 2010, Nano reviews.

[246]  Ovidio Bussolati,et al.  Toxicity determinants of multi-walled carbon nanotubes: The relationship between functionalization and agglomeration , 2016, Toxicology reports.

[247]  Xuefei Zhang,et al.  Evaluation of in vitro toxicity of polymeric micelles to human endothelial cells under different conditions. , 2017, Chemico-biological interactions.

[248]  N. Gu,et al.  The Smart Drug Delivery System and Its Clinical Potential , 2016, Theranostics.

[249]  P. Meers,et al.  Enzyme-activated targeting of liposomes. , 2001, Advanced drug delivery reviews.

[250]  A. Akbarzadeh,et al.  Carbon nanotubes: properties, synthesis, purification, and medical applications , 2014, Nanoscale Research Letters.

[251]  W. E. Billups,et al.  Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. , 2006, Toxicology letters.

[252]  Thomas J. Anchordoquy,et al.  Questioning the use of PEGylation for drug delivery , 2013, Drug Delivery and Translational Research.

[253]  Susan Hua,et al.  Advances and Challenges of Liposome Assisted Drug Delivery , 2015, Front. Pharmacol..

[254]  Christine Allen,et al.  Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. , 2004, Journal of pharmaceutical sciences.

[255]  Jiayi Pan,et al.  Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy , 2017, Molecules.

[256]  Yongyong Li,et al.  Redox Sensitive Nanoparticles with Disulfide Bond Linked Sheddable Shellfor Intracellular Drug Delivery , 2014 .

[257]  J. Brieger,et al.  Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer , 2017, Nanomaterials.

[258]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[259]  Xiaohu Gao,et al.  Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. , 2010, Chemical Society reviews.

[260]  C. Noguez.  Surface Plasmons on Metal Nanoparticles: The Influence of Shape and Physical Environment , 2007 .

[261]  Kohki Mukai,et al.  Molecular beam epitaxial growth of InAs self-assembled quantum dots with light-emission at 1.3 μm , 2000 .

[262]  Tianshu Wu,et al.  Toxicity of quantum dots on respiratory system , 2014, Inhalation toxicology.

[263]  Uday B Kompella,et al.  Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. , 2010, Nanomedicine.

[264]  Sabine Neuss,et al.  Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.

[265]  Francis C Szoka,et al.  Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. , 2002, Bioconjugate chemistry.

[266]  Y. Dumont,et al.  Synthesis and characterization of multifunctional superparamagnetic iron oxide nanoparticles (SPION)/C60 nanocomposites assembled by fullerene–amine click chemistry , 2016 .

[267]  Wayne Ouellette,et al.  Cytotoxicity of mesoporous silica nanomaterials. , 2008, Journal of inorganic biochemistry.

[268]  Thomas L Andresen,et al.  Liposome imaging agents in personalized medicine. , 2012, Advanced drug delivery reviews.

[269]  Stephanie D. Teeter,et al.  Glutathione levels in human tumors , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[270]  M. Prato,et al.  Applications of carbon nanotubes in drug delivery. , 2005, Current opinion in chemical biology.

[271]  Quan Li,et al.  Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells , 2017, Scientific Reports.

[272]  J. Kimling,et al.  Turkevich method for gold nanoparticle synthesis revisited. , 2006, The journal of physical chemistry. B.

[273]  T. Andresen,et al.  Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. , 2005, Progress in lipid research.

[274]  S. Davaran,et al.  Liposome-based drug co-delivery systems in cancer cells. , 2017, Materials science & engineering. C, Materials for biological applications.

[275]  Yan Liu,et al.  Self-Assembled Polymeric Micellar Nanoparticles as Nanocarriers for Poorly Soluble Anticancer Drug Ethaselen , 2009, Nanoscale research letters.

[276]  Vladimir P. Torchilin,et al.  Challenges in Development of Targeted Liposomal Therapeutics , 2012, The AAPS Journal.

[277]  Xiaohua Huang,et al.  Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. , 2005, Nano letters.

[278]  S. Majetich,et al.  Magnetic nanoparticles , 2013, Handbook of Magnetism and Magnetic Materials.

[279]  Seyed Mojtaba Mostafavi,et al.  Multifunctional nanoparticle developments in cancer diagnosis and treatment , 2017 .

[280]  G. Lu,et al.  A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles , 2012 .

[281]  W. Pitt,et al.  Investigating the mechanism of acoustically activated uptake of drugs from Pluronic micelles , 2002, BMC Cancer.

[282]  G. Stoter,et al.  Molecular mechanisms of multidrug resistance in cancer chemotherapy. , 1996, Pathology, research and practice.

[283]  G. Pillai,et al.  Nanomedicines for Cancer Therapy : An Update of FDA Approved and Those under Various Stages of Development , 2014 .

[284]  Jan Feijen,et al.  Thermosensitive Micelle-Forming Block Copolymers of Poly(ethylene glycol) and Poly(N-isopropylacrylamide) , 1997 .

[285]  N. Jacobsen,et al.  Hepatic toxicity assessment of cationic liposome exposure in healthy and chronic alcohol fed mice , 2017, Heliyon.

[286]  Jun Ge,et al.  Drug release from electric-field-responsive nanoparticles. , 2012, ACS nano.

[287]  Hongzhe Sun,et al.  Transferrin-mediated gold nanoparticle cellular uptake. , 2005, Bioconjugate chemistry.

[288]  Ricardas Rotomskis,et al.  Accumulation and Toxicity of Superparamagnetic Iron Oxide Nanoparticles in Cells and Experimental Animals , 2016, International journal of molecular sciences.

[289]  F. Tamanoi,et al.  Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery. , 2012, Therapeutic delivery.

[290]  Kai Yang,et al.  Carbon materials for drug delivery & cancer therapy , 2011 .

[291]  A. Rustgi,et al.  The genetics of hereditary colon cancer. , 2007, Genes & development.

[292]  B. Kim,et al.  Biological synthesis of gold nanoparticles using Magnolia kobus and Diopyros kaki leaf extracts , 2009 .

[293]  N. Phillips,et al.  Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. , 1997, Biochimica et biophysica acta.

[294]  S. Singh,et al.  Functionalized Gold Nanoparticles and Their Biomedical Applications , 2011, Nanomaterials.

[295]  H. Dai,et al.  Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into Mammalian cells. , 2004, Journal of the American Chemical Society.

[296]  Jun Zhou.  Multi-Drug Resistance in Cancer , 2010, Methods in Molecular Biology.

[297]  S. Feng,et al.  Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success , 2013, Expert opinion on drug delivery.

[298]  F. Davis,et al.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.

[299]  D. Deamer.  PREPARATION AND PROPERTIES OF ETHER‐INJECTION LIPOSOMES * , 1978, Annals of the New York Academy of Sciences.

[300]  H. Nowak,et al.  Magnetism in Medicine , 2006 .

[301]  R. Macdonald,et al.  Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. , 2004, Biochimica et biophysica acta.

[302]  S. Lesieur,et al.  Anti‐Estrogen‐Loaded Superparamagnetic Liposomes for Intracellular Magnetic Targeting and Treatment of Breast Cancer Tumors , 2011 .

[303]  E. Buhleier,et al.  "Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies , 1978 .

[304]  Dan Peer,et al.  Altering the immune response with lipid-based nanoparticles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.